Phase 2 prospective analysis of alectinib in ALK-positive, crizotinib-resistant non-small-cell lung...
Phase 2 prospective analysis of alectinib in ALK-positive, crizotinib-resistant non-small-cell lung cancer
About this item
Full title
Author / Creator
Shaw, Alice T. , Gandhi, Leena , Gadgeel, Shirish , Riely, Gregory J. , Cetnar, Jeremy , West, Howard , Camidge, D. Ross , Socinski, Mark A. , Chiappori, Alberto , Mekhail, Tarek , Chao, Bo H. , Borghaei, Hossein , Gold, Kathryn A. , Zeaiter, Ali , Bordogna, Walter , Balas, Bogdana , Puig, Oscar , Henschel, Volkmar and Ignatius Ou, Sai-Hong
Journal title
Language
English
Formats
More information
Alternative Titles
Full title
Phase 2 prospective analysis of alectinib in ALK-positive, crizotinib-resistant non-small-cell lung cancer
Authors, Artists and Contributors
Author / Creator
Gandhi, Leena
Gadgeel, Shirish
Riely, Gregory J.
Cetnar, Jeremy
West, Howard
Camidge, D. Ross
Socinski, Mark A.
Chiappori, Alberto
Mekhail, Tarek
Chao, Bo H.
Borghaei, Hossein
Gold, Kathryn A.
Zeaiter, Ali
Bordogna, Walter
Balas, Bogdana
Puig, Oscar
Henschel, Volkmar
Ignatius Ou, Sai-Hong
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4752892
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4752892
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(15)00488-X
